CoreCap Advisors »

Zenas Biopharma shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $305 12 25.42

More positions owned by CoreCap Advisors

Vanguard Total Stock Market Etf Etf (VTI)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Vanguard Total Bond Market Etf Etf (BND)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard S&p 500 Etf Etf (VOO)
Schwab U.s. Small-cap Etf Etf (SCHA)
Apple Stock (AAPL)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Vanguard Value Etf Etf (VTV)
Nvidia Corporation Stock (NVDA)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Ishares Core S&p 500 Etf Etf (IVV)
State Street Spdr S&p 500 Etf Etf (SPY)

View all positions for CoreCap Advisors

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
Polar Capital Holdings
Capital Research and Management Company - Division 3
Fairmount Funds Management
BlackRock
NVP Associates
State Street Corporation
Wellington Management Company
Vanguard Capital Management
Silverarc Capital Management
Alliancebernstein

View all funds holding Zenas Biopharma